Correspondence | CMAC

Correspondence

What is the Appropriate Time for Administering Probiotics?

Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(3):279-282

Selection of Macrolide Resistance

Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(3):255-259

Strain-specific Effects of Probiotics

Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(3):253-254

Common Questions About the Treatment of Community-Acquired Pneumonia

Clinical Microbiology and Antimicrobial Chemotherapy. 2010; 12(1):82-85

Comments on IDSA Guidelines for the Management of Patients with Candidiasis. Focus on Clinical Use of Caspofungin

Clinical Microbiology and Antimicrobial Chemotherapy.2004; 6(4):394-396

Tympanocentesis: the Risk of Complications is Overestimated

Clinical Microbiology and Antimicrobial Chemotherapy. 2004; 6(2):201-203

To the issue of Antibiotic Policy in Surgery

Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(4):389-392

Reply on the Letter of S.M. Zakharenko «Human Micro-Ecology – Unknown Reality»

Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(1):81-84

Human Micro-Ecology – Unknown Reality

Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(1):79-80
About the article of A.N. Mayanski «Disbacteriosis: Illusion and Reality». Clin Microbiol Antimicrob Chemother 2000; 2(2):61-5

Antimicrobial Resistance of Chlamydia trachomatis

Clinical Microbiology and Antimicrobial Chemotherapy. 2000; 2(2):110